Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
PK and PD Study of NPI-001 and Cysteamine Bitartrate
ClinicalTrials.gov study NCT05994534. IPD Sharing: NO. Countries: 1. Publications: 0.
Motor Response to Sildenafil in PD
ClinicalTrials.gov study NCT01941732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers
ClinicalTrials.gov study NCT03694041. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
ClinicalTrials.gov study NCT07197671. IPD Sharing: YES. Countries: 1. Publications: 0.
PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
ClinicalTrials.gov study NCT07031011. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors
ClinicalTrials.gov study NCT03190811. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjec
ClinicalTrials.gov study NCT03861793. IPD Sharing: NO. Countries: 6. Publications: 0.
Effects of iVR Treadmill on Gait in PD
ClinicalTrials.gov study NCT04019158. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT06086522. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer
ClinicalTrials.gov study NCT03906526. IPD Sharing: YES. Countries: 1. Publications: 0.
Sargramostim (GM-CSF) + PD-1
ClinicalTrials.gov study NCT04703426. IPD Sharing: YES. Countries: 0. Publications: 0.
Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial
ClinicalTrials.gov study NCT04322591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01808482. IPD Sharing: YES. Countries: 1. Publications: 0.
Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%
ClinicalTrials.gov study NCT07215962. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects
ClinicalTrials.gov study NCT01788696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
ClinicalTrials.gov study NCT03815396. IPD Sharing: NO. Countries: 3. Publications: 0.
PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like Carcinoma
ClinicalTrials.gov study NCT04430166. IPD Sharing: NO. Countries: 1. Publications: 0.
XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
ClinicalTrials.gov study NCT05184322. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
ClinicalTrials.gov study NCT05208281. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
ClinicalTrials.gov study NCT05876312. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.